In Kunming mice with status epilepticus, Amentoflavone was administered intragastrically at 25 mg/kg for 3 consecutive days, once a day, prior to pilocarpine injection. The NO and prostaglandin E2 readouts showed significantly decreased production compared to the non-treated epilepsy group (P < 0.01). [2]
Reduced NO Production in Mice With Status Epilepticus
Animal study · Kunming mice (male, 28–32 g, 5–6 weeks old); amentoflavone pre-treated group (n = 30); mice with status epilepticus [2]
Kunming mice with status epilepticus received Amentoflavone intragastrically at 25 mg/kg for 3 consecutive days, once a day, prior to pilocarpine injection. NO production was significantly decreased compared to the non-treated epilepsy group (P < 0.01).
Conditions shared by the study groups
- Route
- intragastrically
- Treatment course
- for 3 consecutive days, once a day, prior to pilocarpine injection
- Vehicle
- gum acacia solution (1%)
- Amentoflavone 25 mg/kg
- Model: Kunming mice (male, 28–32 g, 5–6 weeks old); amentoflavone pre-treated group (n = 30); mice with status epilepticus
Methods and source locations
Compound reported in the paper: Amentoflavone
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Animals (S1); Materials and Methods > Establishment of mouse kindling models and drug administration (S8, S10, S14, S15, S16); Materials and Methods > Nitrite measurement, prostaglandin E2, and cytokine assays (S69); Results > Effects of amentoflavone on NO and prostaglandin E2 production in the hippocampus of mice with status epilepticus (S103); Figure 6 legend (S142)
NO production: NO production; comparator: non-treated epilepsy group — Materials and Methods > Establishment of mouse kindling models and drug administration (S10); Results > Effects of amentoflavone on NO and prostaglandin E2 production in the hippocampus of mice with status epilepticus (S103)
Amentoflavone 25 mg/kg · Materials and Methods > Establishment of mouse kindling models and drug administration (S10); Results > Effects of amentoflavone on NO and prostaglandin E2 production in the hippocampus of mice with status epilepticus (S103)
Reduced Prostaglandin E2 Production in Mice With Status Epilepticus
Animal study · Kunming mice (male, 28–32 g, 5–6 weeks old); amentoflavone pre-treated group (n = 30); mice with status epilepticus [2]
Kunming mice with status epilepticus received Amentoflavone intragastrically at 25 mg/kg for 3 consecutive days, once a day, prior to pilocarpine injection. Prostaglandin E2 production was significantly decreased compared to the non-treated epilepsy group (P < 0.01).
Conditions shared by the study groups
- Route
- intragastrically
- Treatment course
- for 3 consecutive days, once a day, prior to pilocarpine injection
- Vehicle
- gum acacia solution (1%)
- Amentoflavone 25 mg/kg
- Model: Kunming mice (male, 28–32 g, 5–6 weeks old); amentoflavone pre-treated group (n = 30); mice with status epilepticus
Methods and source locations
Compound reported in the paper: Amentoflavone
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Animals (S1); Materials and Methods > Establishment of mouse kindling models and drug administration (S8, S10, S14, S15, S16); Results > Effects of amentoflavone on NO and prostaglandin E2 production in the hippocampus of mice with status epilepticus (S103); Figure 6 legend (S142)
prostaglandin E2 production: prostaglandin E2 production; comparator: non-treated epilepsy group — Materials and Methods > Establishment of mouse kindling models and drug administration (S10); Results > Effects of amentoflavone on NO and prostaglandin E2 production in the hippocampus of mice with status epilepticus (S103)
Amentoflavone 25 mg/kg · Materials and Methods > Establishment of mouse kindling models and drug administration (S10); Results > Effects of amentoflavone on NO and prostaglandin E2 production in the hippocampus of mice with status epilepticus (S103)